Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesPioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes
Atherosclerosis, 06/25/09
Papathanassiou K et al. - In patients with type 2 diabetes already on metformin, addition of pioglitazone as compared to glimepiride, improved endothelial function despite similar glycemic control. The improvement in endothelial function was mainly due to a reduction in insulin resistance.
Related Articles
Pioglitazone Induced Reversible Pancytopenia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09
Relevance Score: 88%
Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09
Relevance Score: 88%
Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09
Relevance Score: 87%
Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)
Diabetic Medicine, 10/02/09
Relevance Score: 87%
Pioglitazone Treatment Enlarges Subcutaneous Adipocytes in Insulin-Resistant Patients
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor